Processa Pharmaceuticals, Inc.
PCSANASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $4.62M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.04$11.00
- Volume (live)
- -
- Avg. volume (3M)
- 138.32K
Processa Pharmaceuticals (PCSA) Stock Price & Financial Analysis
Processa Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.61 - $1.75 |
|---|---|
| 52-Week High | $11.00 |
| 52-Week Low | $1.04 |
| Open | $1.69 |
| Volume (last close) | 22.05K |
| Average Volume (3M) | 138.32K |
| 50-Day MA | $1.99 |
|---|---|
| 200-Day MA | $2.45 |
| 1-Year Change | −78.04% |
| Market Cap | 4.62M |
|---|---|
| Shares Outstanding | 2.75M |
| Price to Book (P/B) | -14.56 |
| EV/EBITDA | -0.35 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Processa Pharmaceuticals at a Glance
As of the Oct 16, 2026 close, Processa Pharmaceuticals (PCSA) has a market capitalization of $4.62M.
As of its latest reported balance sheet, it holds $196.32K in cash and securities against $0.00 of debt, a net cash position of $196.32K.
Processa Pharmaceuticals does not currently pay a dividend.
The share price is down 78.0% over the past year. At $1.68 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $1.04 to $11.00, below its 200-day moving average of $2.45.
Frequently Asked Questions About Processa Pharmaceuticals
What is the current stock price for PCSA?
As of the Oct 16, 2026 close, PCSA stock trades at $1.68. The 52-week range is $1.04–$11.00, with a day range of $1.61–$1.75.
What is the P/E ratio for PCSA?
The P/E ratio (Price-to-Earnings) for PCSA is shown in the Key Statistics section. This valuation metric helps compare Processa Pharmaceuticals, Inc. to industry peers.
Does PCSA pay dividends?
Processa Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PCSA?
Analyst ratings and recommendations for PCSA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of PCSA?
As of the Oct 16, 2026 close, Processa Pharmaceuticals's market capitalization is $4.6M, classifying it as a micro-cap company. Processa Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.